$JAGX

3 stories mentioning JAGXUpdated 45d ago

Every FINWIRES story that references JAGX, newest first.

Jaguar Health Files New Animal Drug Application For Full FDA Approval Of Canine Diarrhea Therapy

Jaguar Health (JAGX) completed the submission of its new animal drug application to the US Food and Drug Administration's Center for Veterinary Medicine, seeking full approval for crofelemer to treat chemotherapy-induced diarrhea in dogs, the company said Tuesday.The application incorporates findings from a clinical efficacy study in veterinary oncology centers alongside data involving subjects undergoing targeted tyrosine kinase inhibitor therapies, the company said.The medication operates as a non-antibiotic treatment mechanism and currently holds conditional agency approval for the canine indication, Jaguar Health said.Shares of the company were down 1.6% in early Tuesday trading.Price: $2.57, Change: $-0.04, Percent Change: -1.61%

$JAGX

Sectors45d ago

Sector Update: Healthcare Stocks Rise Late Afternoon

Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 0.9% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 0.8%.The iShares Biotechnology ETF (IBB) climbed 1.7%.In corporate news, AbbVie (ABBV) has agreed to acquire Apogee Therapeutics (APGE) in an all-cash deal worth about $10.9 billion, as the drugmaker looks to boost its immunology portfolio and accelerate its clinical presence in the respiratory segment. AbbVie shares jumped past 6%, and Apogee surged 46%.Regenxbio (RGNX) shares jumped 18% after it said the US Food and Drug Administration has agreed on the next steps for a potential accelerated approval of Navsunli, its experimental gene therapy for Mucopolysaccharidosis II, following discussions related to its appeal of a complete response letter issued in February.Jaguar Health (JAGX) shares climbed 16% after the firm said Monday its board has started a process to explore strategic alternatives to maximize shareholder value.Vivos Therapeutics (VVOS) shares fell 14% after it said Monday it has extended its strategic financing agreement with Streeterville Capital through Aug. 31, giving it additional time to complete planned capital-raising efforts.

$ABBV$APGE$JAGX$RGNX$VVOS

Sectors46d ago

Sector Update: Healthcare Stocks Rise Monday Afternoon

Healthcare stocks were higher Monday afternoon, with the NYSE Healthcare Index rising 1.4% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 1.2%.The iShares Biotechnology ETF (IBB) rose 1.9%.In corporate news, AbbVie (ABBV) has agreed to acquire Apogee Therapeutics (APGE) in an all-cash deal worth about $10.9 billion, as the drugmaker looks to boost its immunology portfolio and accelerate its clinical presence in the respiratory segment. AbbVie shares jumped past 7%, and Apogee surged 46%.Jaguar Health (JAGX) shares climbed up past 9% after the firm said Monday its board has started a process to explore strategic alternatives to maximize shareholder value.Definium Therapeutics (DFTX) shares soared 55% after the firm said the phase 3 Emerge trial of a single 100-microgram dose of DT120 orally disintegrating tablet in major depressive disorder met the primary endpoint, and all key secondary endpoints.

$ABBV$DFTX$JAGX

Track with the FINWIRES app suite

FolioX

Track JAGX in your portfolio

WheelAI

Analyze JAGX options with the wheel strategy

StockInsider

See market sentiment on JAGX